↓ Skip to main content

Dove Medical Press

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, May 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
82 Mendeley